Revisiting the therapeutic potential of gingerols against different pharmacological activities

© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature..

The rhizomes of ginger have been in use in many forms of traditional and alternative medicines. Besides being employed as condiment and flavoring agent, it is used in the treatment of nausea, osteoarthritis, muscle pain, menstrual pain, chronic indigestion, Alzheimer's disease, and cancer. Ginger rhizome contains volatile oils, phenolic compounds and resins, and characterization studies showed that [6]-gingerol, [6]-shogaol, and [6]-paradol are reported to be the pharmacologically active components. Gingerol is a major chemical constituent found as volatile oil in the rhizomes of ginger. It has several medicinal benefits and used for the treatment of rheumatoid arthritis, nausea, cancer, and diabetes. Many studies have been carried out in various parts of the world to isolate and standardize gingerol for their use as a complementary medicine. The present review summarizes wide range of research studies on gingerol and its pharmacological roles in various metabolic diseases.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:396

Enthalten in:

Naunyn-Schmiedeberg's archives of pharmacology - 396(2023), 4 vom: 30. Apr., Seite 633-647

Sprache:

Englisch

Beteiligte Personen:

Sharma, Samridhi [VerfasserIn]
Shukla, Monu Kumar [VerfasserIn]
Sharma, Krishan Chander [VerfasserIn]
Tirath [VerfasserIn]
Kumar, Lokender [VerfasserIn]
Anal, Jasha Momo H [VerfasserIn]
Upadhyay, Santosh Kumar [VerfasserIn]
Bhattacharyya, Sanjib [VerfasserIn]
Kumar, Deepak [VerfasserIn]

Links:

Volltext

Themen:

925QK2Z900
C5529G5JPQ
Cancer
Catechols
Fatty Alcohols
Ginger
Ginger extract
Gingerol
Inflammation
Journal Article
Plant Extracts
Resins
Review
Volatile oil
Zingiber officinale

Anmerkungen:

Date Completed 29.03.2023

Date Revised 09.01.2024

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1007/s00210-022-02372-7

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM35097327X